| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients.
|
Cancer Chemother Pharmacol
|
2000
|
3.04
|
|
2
|
Clinical pharmacokinetics of capecitabine.
|
Clin Pharmacokinet
|
2001
|
1.91
|
|
3
|
Single-dose pharmacokinetics of Ro 17-2301 (AMA-1080), a monocyclic beta-lactam, in humans.
|
Antimicrob Agents Chemother
|
1984
|
1.70
|
|
4
|
Effect of hepatic dysfunction due to liver metastases on the pharmacokinetics of capecitabine and its metabolites.
|
Clin Cancer Res
|
1999
|
1.57
|
|
5
|
Plasma concentrations in pyrimethamine and sulfadoxine and evaluation of pharmacokinetic data by computerized curve fitting.
|
Bull World Health Organ
|
1982
|
1.57
|
|
6
|
Effect of food on the pharmacokinetics of capecitabine and its metabolites following oral administration in cancer patients.
|
Clin Cancer Res
|
1998
|
1.21
|
|
7
|
A new sensitive, rapid fluorescence technique for the determination of proteins in gel electrophoresis and in solution.
|
Anal Biochem
|
1973
|
1.17
|
|
8
|
Hydrophobic binding sites in bovine serum albumin and erythrocyte ghost proteins. Study by spin-labelling, paramagnetic fluorescence quenching and chemical modification.
|
Biochim Biophys Acta
|
1974
|
1.09
|
|
9
|
Erythrocyte membrane alterations due to infection with Plasmodium berghei.
|
Biochim Biophys Acta
|
1973
|
1.06
|
|
10
|
Pharmacokinetics of carumonam in patients with renal insufficiency.
|
Antimicrob Agents Chemother
|
1986
|
1.01
|
|
11
|
Bioequivalence of two tablet formulations of capecitabine and exploration of age, gender, body surface area, and creatinine clearance as factors influencing systemic exposure in cancer patients.
|
Cancer Chemother Pharmacol
|
1999
|
0.99
|
|
12
|
Single-dose investigation of possible interactions between the components of the antimalarial combination Fansimef.
|
Chemotherapy
|
1987
|
0.95
|
|
13
|
Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patients.
|
Antimicrob Agents Chemother
|
1990
|
0.94
|
|
14
|
The study of lipid-protein interactions in membranes by fluorescent probes.
|
Biochim Biophys Acta
|
1970
|
0.93
|
|
15
|
Raman and infrared spectroscopic study of gramicidin A conformations.
|
Arch Biochem Biophys
|
1980
|
0.92
|
|
16
|
Plasma concentrations of sulfadoxine in healthy and malaria infected Thai subjects.
|
Acta Trop
|
1988
|
0.89
|
|
17
|
Multiple-dose pharmacokinetics of the antimalarial drug Fansimef (pyrimethamine + sulfadoxine + mefloquine) in healthy subjects.
|
Chemotherapy
|
1987
|
0.89
|
|
18
|
Influence of the antacid Maalox on the pharmacokinetics of capecitabine in cancer patients.
|
Cancer Chemother Pharmacol
|
1999
|
0.87
|
|
19
|
Pharmacokinetics and metabolism of intravenous and oral fleroxacin in subjects with normal and impaired renal function and in patients on continuous ambulatory peritoneal dialysis.
|
Antimicrob Agents Chemother
|
1989
|
0.87
|
|
20
|
Fleroxacin: a review of its chemistry, microbiology, toxicology, pharmacokinetics, clinical efficacy and safety.
|
Int J Antimicrob Agents
|
1993
|
0.85
|
|
21
|
Extraction and localization of a (Ca2+ and Mg2+)-stimulated ATPase in human erythrocyte spectrin.
|
Biochim Biophys Acta
|
1975
|
0.85
|
|
22
|
Penetration of fleroxacin into human and animal tissues.
|
Chemotherapy
|
1992
|
0.84
|
|
23
|
Raman spectroscopic investigation of the interaction of gramicidin A with dipalmitoyl phosphatidylcholine liposomes.
|
Biochim Biophys Acta
|
1977
|
0.84
|
|
24
|
Physical properties of muscle cell membranes during fusion. A fluorescence polarization study with the ionophore A23187.
|
Biochim Biophys Acta
|
1976
|
0.83
|
|
25
|
Fleroxacin concentrations in myometrium, ovary and fallopian tube.
|
J Antimicrob Chemother
|
1989
|
0.82
|
|
26
|
Micromorphologic consequences following perturbation of erythrocyte membranes by trypsin, phospholipase A, lysolecithin, sodium dodecyl sulfate and saponin. A correlated freeze-etching and biochemical study.
|
Biochim Biophys Acta
|
1972
|
0.81
|
|
27
|
Biochemical characterization of segreated membrane vesicles from human erythrocytes with increased intracellular Ca2+.
|
Arch Biochem Biophys
|
1977
|
0.80
|
|
28
|
Influence of alitretinoin on the pharmacokinetics of the oral contraceptive ethinyl estradiol/norgestimate.
|
Clin Exp Dermatol
|
2011
|
0.78
|
|
29
|
Penetration of fleroxacin into breast milk and pharmacokinetics in lactating women.
|
Antimicrob Agents Chemother
|
1993
|
0.78
|
|
30
|
The effect of phospholipase A upon the interaction of I-anilinonaphthalene-8-sulfonate with erythrocyte membranes.
|
Biochim Biophys Acta
|
1971
|
0.78
|
|
31
|
Single-dose pharmacokinetics of oral fleroxacin in bacteremic patients.
|
Antimicrob Agents Chemother
|
1994
|
0.77
|
|
32
|
Pharmacokinetics and safety of candesartan cilexetil in subjects with normal and impaired liver function.
|
Eur J Clin Pharmacol
|
1998
|
0.77
|
|
33
|
Phospholipid composition of human erythrocyte spectrin.
|
Mol Biol Rep
|
1978
|
0.77
|
|
34
|
Influence of rifampin on fleroxacin pharmacokinetics.
|
Antimicrob Agents Chemother
|
1993
|
0.76
|
|
35
|
[Radiation effects in biomembranes (author's transl)].
|
Klin Wochenschr
|
1973
|
0.75
|
|
36
|
Pre-resonance Raman spectra and conformations of nystatin in powder, solution and phospholipid-cholesterol multilayers.
|
Biochim Biophys Acta
|
1979
|
0.75
|
|
37
|
Pharmacokinetics of tenoxicam in patients with impaired renal function.
|
Eur J Clin Pharmacol
|
1986
|
0.75
|
|
38
|
Determination of pyrimethamine in human plasma after administration of fansidar of fansidar-mefloquine by means of high-performance liquid chromatography with fluorescence detection.
|
J Chromatogr
|
1982
|
0.75
|
|
39
|
Low levels of alitretinoin in seminal fluids after repeated oral doses in healthy men.
|
Clin Exp Dermatol
|
2011
|
0.75
|
|
40
|
Laser-Raman study of valinomycin-doped and omega-CD3-labeled phosphatidylcholine liposomes.
|
Arch Biochem Biophys
|
1978
|
0.75
|
|
41
|
Pharmacokinetics and pharmacodynamics of mibefradil in hypertensive patients with varying degrees of renal insufficiency.
|
Pharmacology
|
1998
|
0.75
|
|
42
|
Absence of pharmacokinetic interaction between Fansidar and mefloquine.
|
Trans R Soc Trop Med Hyg
|
1986
|
0.75
|
|
43
|
A new trifluorinated quinolone: Ro 23-6240 (AM 833).
|
Drugs Exp Clin Res
|
1987
|
0.75
|
|
44
|
Analysis of polyacrylamide gel electrophoresis through the PIQUANT image recognition system.
|
Anal Biochem
|
1974
|
0.75
|
|
45
|
Multiple intravenous dose pharmacokinetic study of carumonam in healthy subjects.
|
J Antimicrob Chemother
|
1989
|
0.75
|